Advertisement
Screener

PRECISION BIOSCIENCES INC (DTIL) Noncash or Part Noncash Acquisition, Fixed Assets Acquired

2.2 / 5 stars · 31/70 Roast Me

PRECISION BIOSCIENCES INC Noncash or Part Noncash Acquisition, Fixed Assets Acquired

PRECISION BIOSCIENCES INC (DTIL) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-05-05

  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was -$400.00K, a 933.33% decline year-over-year.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was $400.00K.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was -$1.00K.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $48.00K, a 242.86% increase from fiscal 2023.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $14.00K, a 86.41% decline from fiscal 2022.
  • PRECISION BIOSCIENCES INC noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $103.00K, a 0.00% change from fiscal 2021.
Period endNoncash or Part Noncash Acquisition, Fixed Assets Acquired 3 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 6 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 9 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month
2026-03-31$0.00
10-Q · filed 2026-05-05
-$400.00K
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
-$1.00K
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31-$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$0.00
derived: sum of 2 quarters · filed 2026-03-12
-$1.00K
derived: sum of 3 quarters · filed 2026-03-12
$0.00
10-K · filed 2026-03-12
2025-09-30$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$399.00K
derived: sum of 2 quarters · filed 2025-11-03
$400.00K
10-Q · filed 2025-11-03
$448.00K
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$48.00K
derived: sum of 3 quarters · filed 2026-05-05
$48.00K
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31$1.00K
10-Q · filed 2026-05-05
$49.00K
derived: sum of 2 quarters · filed 2026-05-05
$49.00K
derived: sum of 3 quarters · filed 2026-05-05
$43.00K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$48.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$48.00K
derived: sum of 2 quarters · filed 2026-03-12
$42.00K
derived: sum of 3 quarters · filed 2026-03-12
$48.00K
10-K · filed 2026-03-12
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
-$6.00K
derived: sum of 2 quarters · filed 2025-11-03
$0.00
10-Q · filed 2025-11-03
2024-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
2024-03-31$6.00K
10-Q · filed 2025-05-15
2023-12-31$14.00K
10-K · filed 2025-03-26
2023-06-30-$39.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$4.00K
10-Q · filed 2024-08-01
-$125.00K
derived: sum of 3 quarters · filed 2024-08-01
-$398.00K
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$43.00K
10-Q · filed 2024-05-13
-$86.00K
derived: sum of 2 quarters · filed 2024-05-13
-$359.00K
derived: sum of 3 quarters · filed 2024-05-13
$72.00K
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$129.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
-$402.00K
derived: sum of 2 quarters · filed 2024-03-27
$29.00K
derived: sum of 3 quarters · filed 2024-03-27
$103.00K
10-K · filed 2024-03-27
2022-09-30-$273.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$158.00K
derived: sum of 2 quarters · filed 2023-11-07
$232.00K
10-Q · filed 2023-11-07
-$360.00K
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$431.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$505.00K
10-Q · filed 2023-08-04
-$87.00K
derived: sum of 3 quarters · filed 2023-08-04
$300.00K
derived: sum of 4 quarters · filed 2023-08-04
2022-03-31$74.00K
10-Q · filed 2023-05-09
-$518.00K
derived: sum of 2 quarters · filed 2023-05-09
-$131.00K
derived: sum of 3 quarters · filed 2023-05-09
-$460.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$592.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$205.00K
derived: sum of 2 quarters · filed 2023-03-09
-$534.00K
derived: sum of 3 quarters · filed 2023-03-09
$103.00K
10-K · filed 2023-03-09
2021-09-30$387.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$58.00K
derived: sum of 2 quarters · filed 2022-11-08
$695.00K
10-Q · filed 2022-11-08
$509.00K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$329.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$308.00K
10-Q · filed 2022-08-08
$122.00K
derived: sum of 3 quarters · filed 2022-08-08
$502.00K
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$637.00K
10-Q · filed 2022-05-09
$451.00K
derived: sum of 2 quarters · filed 2022-05-09
$831.00K
derived: sum of 3 quarters · filed 2022-05-09
$651.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$186.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$194.00K
derived: sum of 2 quarters · filed 2022-03-15
$14.00K
derived: sum of 3 quarters · filed 2022-03-15
$665.00K
10-K · filed 2022-03-15
2020-09-30$380.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$200.00K
derived: sum of 2 quarters · filed 2021-11-10
$851.00K
10-Q · filed 2021-11-10
-$2.27M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$180.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$471.00K
10-Q · filed 2021-08-12
-$2.65M
derived: sum of 3 quarters · filed 2021-08-12
-$1.18M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$651.00K
10-Q · filed 2021-05-13
-$2.47M
derived: sum of 2 quarters · filed 2021-05-13
-$1.00M
derived: sum of 3 quarters · filed 2021-05-13
-$2.90M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$1.65M
derived: sum of 2 quarters · filed 2021-03-18
-$3.55M
derived: sum of 3 quarters · filed 2021-03-18
$401.00K
10-K · filed 2021-03-18
2019-09-30$1.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$427.00K
derived: sum of 2 quarters · filed 2020-11-10
$3.52M
10-Q · filed 2020-11-10
$2.68M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30-$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$2.05M
10-Q · filed 2020-08-13
$1.21M
derived: sum of 3 quarters · filed 2020-08-13
$2.30M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$3.95M
10-Q · filed 2020-05-15
$3.10M
derived: sum of 2 quarters · filed 2020-05-15
$4.20M
derived: sum of 3 quarters · filed 2020-05-15
$4.64M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$847.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$252.00K
derived: sum of 2 quarters · filed 2020-03-10
$688.00K
derived: sum of 3 quarters · filed 2020-03-10
$1.34M
10-K · filed 2020-03-10
2018-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.53M
derived: sum of 2 quarters · filed 2019-11-12
$2.19M
10-Q · filed 2019-11-12
2018-06-30$436.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.09M
10-Q · filed 2019-08-14
2018-03-31$652.00K
10-Q · filed 2019-04-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alector, Inc. (ALEC)United States$0.213B-1.90